ˇ
´
939
A. Knezevic et al. / Tetrahedron: Asymmetry 22 (2011) 936–941
4.3.6. (E)-3-(4-Methylnaphthalen-1-yl)-prop-2-en-1-ol 3f
White solid (1.72 g, 99%) starting from 2f (2.12 g); mp 100.2–
101.1 °C;
5.90 (1H, dt, J = 6.1, 16.3 Hz, CHCH2), 5.00 (2H, dd, J = 1.2, 6.1 Hz,
CHCH2), 2.27 (9H, s, ArCH3); 13C NMR (75 MHz, CDCl3) d 162.47,
136.56, 135.89, 132.99, 132.79, 128.59, 127.24, 69.70, 20.91, 20.76.
m
max/cmꢁ1 3340, 1412, 1015, 966, 840, 752. 1H NMR
(300 MHz, CDCl3) d 8.16–8.13 (1H, m, Ar), 8.04–8.01 (1H, m, Ar),
7.57–7.49 (3H, m, Ar), 7.37 (1H, d, J = 15.7 Hz, CH), 7.30 (1H, d,
J = 7.3 Hz, Ar), 6.36 (1H, dt, J = 5.7, 15.7 Hz, CHCH2), 4.43 (2H, d,
J = 5.7 Hz, CHCH2), 2.70 (3H, s, ArCH3), 1.61 (1H, br s, OH), 13C NMR
(75 MHz, CDCl3) d 134.36, 132.83, 132.63, 131.23, 131.08, 128.56,
126.50, 125.71, 125.65, 124.65, 124.31, 123.71, 64.04, 19.60.
4.4.6. (E)-3-(4-Methylnaphthalen-1-yl)-allyl-2,2,2-trichloro-
acetimidate 4f
Yellow oil (2.86 g, 96%) starting from 3f (1.72 g).
m
max/cmꢁ1
3375, 1695, 1385, 1112, 968, 835, 753. 1H NMR (300 MHz, CDCl3)
d 8.41 (1H, br s, NH), 8.14–8.12 (1H, m, Ar), 8.04–8.02 (1H, m,
Ar), 7.55–7.51 (4H, m, Ar, CH), 7.31 (1H, d, J = 7.44 Hz, Ar), 6.39
(1H, dt, J = 6.0, 15.6 Hz, CHCH2), 5.09 (2H, dd, J = 1.3, 6.0 Hz,
CHCH2), 2.70 (3H, s, ArCH3); 13C NMR (75 MHz, CDCl3) d 162.60,
134.84, 132.65, 132.35, 131.89, 131.24, 126.49, 125.89, 125.73,
124.79, 124.70, 124.24, 123.94, 69.88, 19.67.
4.4. General procedure for the synthesis of trichloroacetimid-
ates 4a–f
To a solution of the corresponding alcohol (1 equiv) and DBU
(0.2 equiv) in dry CH2Cl2 (6 mL per 1 mmol of alcohol) at 0 °C, tri-
chloroacetonitrile (1.1 equiv) was added dropwise. The reaction
mixture was stirred for 15 min. The solvent was evaporated to give
a brown residue which was filtered through a short column of neu-
tral aluminium oxide, activity I (eluent EtOAc/hexane = 10:90) to
afford the product.
4.4.7. (E)-3-Phenylallyl-2,2,2-trichloroacetimidate 4g
Yellow oil (1.06 g, 98%) starting from cinammyl alcohol
(0.52 g).7a
4.5. General procedure for the synthesis of amides 5a–g
To
a solution of the corresponding trichloroacetimidate
4.4.1. (E)-3-(1-Naphthalenyl)allyl-2,2,2-trichloroacetimidate 4a
(1 equiv) in xylene (6 mL per 1 mmol of trichloroacetimidate),
K2CO3 (2 mg/mL xylene) was added and the mixture was refluxed
at 140 °C for 24 h. The reaction mixture was cooled to room tem-
perature, concentrated under reduced pressure, and filtered
through a short column of silica gel (eluent toluene) to give a
product.
Yellow oil (9.0 g, 95%) starting from 3a (5.3 g).
m
max/cmꢁ1
3340, 1667, 1306, 1079, 970, 795. 1H NMR (300 MHz, CDCl3) d
8.42 (1H, br s, NH), 8.11 (1H, d, J = 8.0 Hz, Ar), 7.87–7.79 (2H, m,
Ar), 7.64 (1H, d, J = 7.1 Hz, Ar), 7.56–7.43 (4H, m, Ar, CH), 6.43
(1H, dt, J = 6.0, 15.6 Hz, CHCH2), 5.10 (2H, d, J = 5.9 Hz, CHCH2);
13C NMR (75 MHz, CDCl3) d 162.57, 133.96, 133.61, 131.51,
131.16, 128.58, 128.47, 126.25, 125.88, 125.58, 125.53, 124.15,
123.66, 69.71.
4.5.1. 2,2,2-Trichloro-N-[1-(1-naphthalenyl)allyl]acetamide 5a
White solid (7.75 g, 96%) starting from 4a (8.08 g); mp 109.3–
110.2 °C; C15H12Cl3NO requires C, 54.82; H, 3.68; N, 4.26, found:
C, 55.28; H, 3.52; N, 4.00. m
max/cmꢁ1 3284, 1685, 1526, 838, 823,
4.4.2. (E)-3-(4-Methylphenyl)allyl-2,2,2-trichloroacetimidate 4b
Yellow oil (3.97 g, 89%) starting from 3b (2.27 g).
m
max/cmꢁ1
804. 1H NMR (300 MHz, CDCl3) d 8.03 (1H, d, J = 8.2 Hz, Ar), 7.89
(2H, t, J = 9.2 Hz, Ar), 7.61–7.45 (4H, m, Ar), 6.89 (1H, br s, NH),
6.38–6.32 (1H, m, CHNH), 6.25 (1H, ddd, J = 4.4, 10.3, 17.3 Hz,
CHCH2), 5.46 (1H, d, J = 10.3, CH2CH), 5.41 (1H, d, J = 17.3, CH2CH);
13C NMR (75 MHz, CDCl3) d 161.02, 135.36, 134.27, 134.09, 131.13,
129.48, 129.00, 127.09, 126.26, 125.25, 125.20, 123.03, 116.74,
53.29.
3344, 1716, 1664, 1308, 1289, 1078, 968, 798. 1H NMR
(300 MHz, CDCl3) d 8.35 (1H, br s, NH), 7.32 (2H, d, J = 8.0 Hz, Ar),
7.14 (2H, d, J = 8.0 Hz, Ar), 6.73 (1H, d, J = 15.9 Hz, CH), 6.35 (1H,
dt, J = 6.3, 15.9 Hz, CHCH2), 4.96 (2H, dd, J = 1.2, 6.3 Hz, CHCH2),
2.35 (3H, s, ArCH3); 13C NMR (75 MHz, CDCl3) d 162.58, 138.07,
134.59, 133.36, 129.30, 126.62, 121.24, 69.93, 21.22.
4.5.2. 2,2,2-Trichloro-N-[1-(4-methylphenyl)allyl]acetamide 5b
White solid (3.56 g, 95%) starting from 4b (3.74 g); mp 78.5–
79.1 °C.
(300 MHz, CDCl3) d 7.20 (4H, s, Ar), 6.89 (1H, br s, NH), 6.04 (1H,
ddd, J = 5.3, 10.3, 17.2 Hz, CHCH2), 5.56–5.49 (1H, m, CHNH), 5.33
(1H, d, J = 10.3, CH2CH), 5.30 (1H, d, J = 17.2, CH2CH), 2.35 (3H, s,
ArCH3) ; 13C NMR (75 MHz, CDCl3) d 160.88, 138.18, 135.81,
135.74, 129.73, 127.07, 116.83, 56.85, 21.14.
4.4.3. (E)-3-(3,5-Dimethylphenyl)allyl-2,2,2-trichloroacetimid-
ate 4c
m
max/cmꢁ1 3297, 1695, 1523, 837, 819, 805. 1H NMR
Yellow oil (1.34 g, 93%) starting from 3c (0.77 g).
m
max/cmꢁ1
3376, 1696, 1608, 1381, 1110, 968, 837. 1H NMR (300 MHz, CDCl3)
d 8.35 (1H, br s, NH), 7.05 (2H, s, Ar), 6.92 (1H, s, Ar), 6.70 (1H, d,
J = 15.8 Hz, CH), 6.37 (1H, dt, J = 6.3, 15.8 Hz, CHCH2), 4.96 (2H,
dd, J = 1.2, 6.3 Hz, CHCH2), 2.32 (6H, s, ArCH3); 13C NMR (75 MHz,
CDCl3) d 162.60, 138.08, 136.09, 134.81, 129.88, 124.60, 121.93,
69.88, 21.21.
4.5.3. 2,2,2-Trichloro-N-[1-(3,5-dimethylphenyl)allyl]acetamide
5c
4.4.4. (E)-3-(2-Methylphenyl)allyl-2,2,2-trichloroacetimidate 4d
White solid (2.84 g, 95%) starting from 4c (2.98 g); mp 85.8–
Yellow oil (1.3 g, 94%) starting from 3d (0.70 g).
m
max/cmꢁ1
86.8 °C.
m
max/cmꢁ1 3294, 1698, 1529, 831, 822. 1H NMR
3343, 1668, 1308, 1285, 1078, 968, 798, 745. 1H NMR (300 MHz,
CDCl3) d 8.37 (1H, br s, NH), 7.49–7.45 (1H, m, Ar), 7.20–7.15
(3H, m, Ar), 6.99 (1H, d, J = 15.9 Hz, CH), 6.28 (1H, dt, J = 6.1,
15.9 Hz, CHCH2), 5.00 (2H, dd, J = 1.4, 6.1 Hz, CHCH2), 2.36 (3H, s,
ArCH3); 13C NMR (75 MHz, CDCl3) d 162.54, 135.73, 135.34,
132.22, 130.34, 127.99, 126.14, 125.84, 123.60, 69.78, 19.72.
(300 MHz, CDCl3) d 6.97 (1H, s, Ar), 6.93 (2H, s, Ar), 6.86 (1H, br
s, NH), 6.04 (1H, ddd, J = 5.3, 10.1, 17.4 Hz, CHCH2), 5.52–5.46
(1H, m, CHNH), 5.33 (1H, d, J = 10.1, CH2CH), 5.32 (1H, d, J = 17.4,
CH2CH), 2.33 (6H, s, ArCH3); 13C NMR (75 MHz, CDCl3) d 160.84,
138.73, 138.69, 135.82, 129.98, 124.89, 116.58, 57.07, 21.30.
4.5.4. 2,2,2-Trichloro-N-[1-(2-methylphenyl)allyl]acetamide 5d
White solid (1.69 g, 96%) starting from 4d (1.75 g); mp 69.2–
4.4.5. (E)-3-(2,4,6-Trimethylphenyl)allyl-2,2,2-trichloroacetim-
idate 4e
69.9 °C. m
max/cmꢁ1 3300, 1690, 1516, 836, 823, 758, 726. 1H NMR
Colorless oil (0.87 g, 95%) starting from 3e (0.5 g).
m
max/cmꢁ1
(300 MHz, CDCl3) d 7.24 (4H, s, Ar), 6.79 (1H, br s, NH), 6.06 (1H,
ddd, J = 4.6, 10.4, 17.2 Hz, CHCH2), 5.77–5.72 (1H, m, CHNH), 5.35
(1H, d, J = 10.4, CH2CH), 5.26 (1H, d, J = 17.2, CH2CH), 2.39 (3H, s,
3346, 1667, 1302, 1078, 979, 794. 1H NMR (300 MHz, CDCl3) d
8.36 (1H, br s, NH), 6.87 (2H, s, Ar), 6.75 (1H, d, J = 16.3 Hz, CH),